Provided by Tiger Trade Technology Pte. Ltd.

Cheer Holding, Inc.

0.8218
-0.0158-1.89%
Post-market: 0.83800.0162+1.97%19:50 EDT
Volume:26.20K
Turnover:21.72K
Market Cap:3.85M
PE:0.03
High:0.8500
Open:0.8208
Low:0.8040
Close:0.8376
52wk High:104.50
52wk Low:0.8040
Shares:4.69M
Float Shares:2.14M
Volume Ratio:0.52
T/O Rate:1.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):24.07
EPS(LYR):24.07
ROE:7.59%
ROA:4.39%
PB:0.01
PE(LYR):0.03

Loading ...

Cheer Holding FY EPS $24.07 Down From $125.72 YoY, Sales $148.835M Up From $147.196M YoY

Benzinga
·
Mar 23

Cheer Holding FY 2025 cash and cash equivalents rise 22.46% to USD 242 million

Reuters
·
Mar 23

Press Release: Cheer Holding Announces Fiscal Year 2025 Financial Results

Dow Jones
·
Mar 23

Cheer Holding Announces Fiscal Year 2025 Financial Results

GlobeNewswire
·
Mar 23

Cheer Holding Reports Strong 2025 Performance with Revenue Nearing $150 Million

Stock News
·
Mar 23

Cheer Holding Inc. held an extraordinary general meeting and shareholders approved a USD 500,700 authorized share capital reduction

Reuters
·
Mar 17

Cheer Holding Announces Results of Extraordinary General Meeting

GlobeNewswire
·
Mar 17

Cheer Holding Inc. Files Initial Beneficial Ownership Statement for Director Lu Jia

Reuters
·
Mar 14

Cheer Holding Inc. Files Initial Beneficial Ownership Statement for CEO and Director Zhang Bing

Reuters
·
Mar 14

RBC Capital Remains a Buy on Chorus Aviation (CHR)

TIPRANKS
·
Feb 19

CIBC Reaffirms Their Buy Rating on Chorus Aviation (CHR)

TIPRANKS
·
Feb 18

RBC Capital Sticks to Their Buy Rating for Chorus Aviation (CHR)

TIPRANKS
·
Jan 13

NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM

Reuters
·
Dec 23, 2025

BRIEF-Cheer Holding Inc Plans 1-For-50 Share Consolidation Of Class A Ordinary Shares

Reuters
·
Dec 19, 2025

Cheer Holding Inc: Plans 1-for-50 Share Consolidation of Class a Ordinary Shares

THOMSON REUTERS
·
Dec 19, 2025

Cheer Holding Announces 1-for-50 Share Consolidation

Reuters
·
Dec 19, 2025

Cheer Holding Announces Share Consolidation of Class A Ordinary Shares

GlobeNewswire
·
Dec 19, 2025

ASH 2025 | Ascentage Pharma Presents Four-Year Follow-Up Data from Registrational Phase II Study of Olverembatinib, Reaffirming Differentiated Long-Term Efficacy and Safety in TKI-Resistant/Intolerant CML-CP

GlobeNewswire
·
Dec 09, 2025

12 Pairs Gone: Binance Confirms Massive Crypto Margin Delisting in December

utoday
·
Nov 28, 2025

Cheer Holding Receives Nasdaq Delisting Notice Subject to Hearing Request

GlobeNewswire
·
Nov 22, 2025